OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SGLT2 Inhibitor Use in Chronic Kidney Disease: Supporting Cardiovascular, Kidney, and Metabolic Health
Magdalena Madero, Glenn M. Chertow, Patrick B. Mark
Kidney Medicine (2024) Vol. 6, Iss. 8, pp. 100851-100851
Open Access | Times Cited: 10
Magdalena Madero, Glenn M. Chertow, Patrick B. Mark
Kidney Medicine (2024) Vol. 6, Iss. 8, pp. 100851-100851
Open Access | Times Cited: 10
Showing 10 citing articles:
Early Identification and Management of Chronic Kidney Disease: A Narrative Review of the Crucial Role of Primary Care Practitioners
Pamela Kushner, Kamlesh Khunti, Ana Cebrián, et al.
Advances in Therapy (2024) Vol. 41, Iss. 10, pp. 3757-3770
Open Access | Times Cited: 7
Pamela Kushner, Kamlesh Khunti, Ana Cebrián, et al.
Advances in Therapy (2024) Vol. 41, Iss. 10, pp. 3757-3770
Open Access | Times Cited: 7
Letter: Cardiovascular Events in Chronic Kidney Diseases: Related Factors Besides Naples Prognostic Score
Yusuf Ziya Şener, Arzu Yazar
Angiology (2025)
Closed Access
Yusuf Ziya Şener, Arzu Yazar
Angiology (2025)
Closed Access
Challenges, current innovations, and opportunities for managing type 2 diabetes in frail older adults: a position paper of the European Geriatric Medicine Society (EuGMS)—Special Interest Group in Diabetes
Virginia Boccardi, Gülistan Bahat, Cafer Balcı, et al.
European Geriatric Medicine (2025)
Open Access
Virginia Boccardi, Gülistan Bahat, Cafer Balcı, et al.
European Geriatric Medicine (2025)
Open Access
SGLT-2i—A Useful Tool for Real-Life Metabolic and Body Weight Control in Type 2 Diabetes Mellitus Patients
Mihaela-Simona Popoviciu, Teodor Salmen, Delia Reurean‐Pintilei, et al.
Medicina (2025) Vol. 61, Iss. 3, pp. 548-548
Open Access
Mihaela-Simona Popoviciu, Teodor Salmen, Delia Reurean‐Pintilei, et al.
Medicina (2025) Vol. 61, Iss. 3, pp. 548-548
Open Access
Updates in chronic kidney disease management: A systematic review
Amina Ammar, Stephanie B. Edwin, Rachel Whitney, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2025)
Open Access
Amina Ammar, Stephanie B. Edwin, Rachel Whitney, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2025)
Open Access
Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure
Matteo Armillotta, Francesco Angeli, Pasquale Paolisso, et al.
Pharmacology & Therapeutics (2025) Vol. 270, pp. 108861-108861
Open Access
Matteo Armillotta, Francesco Angeli, Pasquale Paolisso, et al.
Pharmacology & Therapeutics (2025) Vol. 270, pp. 108861-108861
Open Access
Dapagliflozin ameliorates intestinal stem cell aging by regulating the MAPK signaling pathway in Drosophila
Jinhua Yan, Chenxi Feng, H Zhang, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Jinhua Yan, Chenxi Feng, H Zhang, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Semaglutide for Chronic Kidney Disease in Type 2 Diabetes
Vlado Perkovic, Katherine R. Tuttle, Richard E. Pratley
New England Journal of Medicine (2024) Vol. 391, Iss. 18, pp. 1757-1757
Closed Access | Times Cited: 2
Vlado Perkovic, Katherine R. Tuttle, Richard E. Pratley
New England Journal of Medicine (2024) Vol. 391, Iss. 18, pp. 1757-1757
Closed Access | Times Cited: 2
Empagliflozin attenuates hypoxia-induced heart failure of zebrafish embryos via influencing MMP13 expression
R Huttunen, A-M Haapanen-Saaristo, Anja Hjelt, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117453-117453
Open Access | Times Cited: 1
R Huttunen, A-M Haapanen-Saaristo, Anja Hjelt, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117453-117453
Open Access | Times Cited: 1
efficacy and safety of dapagliflozin in patients with ckd: Real world experience in 93 italian renal clinics
Roberto Minutolo, Silvio Borrelli, A Ambrosini, et al.
Clinical Kidney Journal (2024) Vol. 18, Iss. 1
Open Access
Roberto Minutolo, Silvio Borrelli, A Ambrosini, et al.
Clinical Kidney Journal (2024) Vol. 18, Iss. 1
Open Access
